Home Minimum analytical quality specifications of inter-laboratory comparisons: agreement among Spanish EQAP organizers
Article
Licensed
Unlicensed Requires Authentication

Minimum analytical quality specifications of inter-laboratory comparisons: agreement among Spanish EQAP organizers

  • Carmen Ricós EMAIL logo , Francisco Ramón , Angel Salas , Antonio Buño , Rafael Calafell , Jorge Morancho , Gabriella Gutiérrez-Bassini , Josep M. Jou and Interdisciplinary Expert Committee for Quality Specifications in the Clinical Laboratory
Published/Copyright: November 18, 2011

Abstract

Background: Four Spanish scientific societies organizing external quality assessment programs (EQAP) formed a working group to promote the use of common minimum quality specifications for clinical tests. Laboratories that do not meet the minimum specifications are encouraged to make immediate review of the analytical procedure affected and to implement corrective actions if necessary.

Methods: The philosophy was to use the 95th percentile of results sent to EQAP (expressed in terms of percentage deviation from the target value) obtained for all results (except the outliers) during a cycle of 1 year. The target value for a number of analytes of the basic biochemistry program was established as the overall mean. However, because of the substantial discrepancies between routine methods for basic hematology, hormones, proteins, therapeutic drugs and tumor markers, the target in these cases was the peer group mean.

Results: The resulting specifications were quite similar to those established in the US (CLIA), and Germany (Richtlinie).

Conclusions: The proposed specifications stand for the minimum level of quality to be attained for laboratories, to assure harmonized service performance. They have nothing to do with satisfying clinical requirements, which are the final level of quality to be reached, and that is strongly recommended in our organizations by means of documents, courses, symposiums and all types of educational activities.


Corresponding author: Carmen Ricós, Sociedad Española de Bioquímica Clínica y Patología Molecular, Quality Committee, Padilla, 323, Barcelona 08025, Spain Phone: +34 93 446 26 70, Fax: +34 93 446 26 72

Received: 2011-6-27
Accepted: 2011-10-19
Published Online: 2011-11-18
Published in Print: 2012-03-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Editorials
  2. An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports
  3. Cancer diagnosis: from dogs to DNA or from DNA to dogs?
  4. The never-ending search of an acceptable compromise for pancreatic lipase standardisation
  5. Review
  6. Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges
  7. Mini Review
  8. Canine olfactory detection of cancer versus laboratory testing: myth or opportunity?
  9. Genetics and Molecular Diagnostics
  10. SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in Southern Brazilians
  11. Elevated plasma matrix metalloproteinase-9 protein and its gene polymorphism in patients with community-acquired pneumonia
  12. General Clinical Chemistry and Laboratory Medicine
  13. Minimum analytical quality specifications of inter-laboratory comparisons: agreement among Spanish EQAP organizers
  14. Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement
  15. Speed of sample transportation by a pneumatic tube system can influence the degree of hemolysis
  16. 1,2-Dioleoylglycerol method for pancreatic lipase catalytic activity in serum
  17. Serum lactate dehydrogenase levels significantly correlate with radiological extent of disease and spirometric values in patients with silicosis due to denim sandblasting
  18. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis
  19. The relationship between antinuclear antibody data and antibodies against extractable nuclear antigens in a large laboratory cohort
  20. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis
  21. Trueness in the measurement of haemoglobin: consensus or reference method?
  22. Soluble transcobalamin receptor, sCD320, is present in human serum and relates to serum cobalamin – establishment and validation of an ELISA
  23. An on-line solid phase extraction procedure for the routine quantification of caspofungin by liquid chromatography-tandem mass spectrometry
  24. Effects of subcutaneous low molecular weight heparin and intravenous unfractionated heparin on serum S100 concentrations in patients with cerebrovascular diseases
  25. Urinary 8-hydroxy-2′-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer’s disease
  26. A HPLC-MS method to detect and quantify guanfacine in urine
  27. Collection and storage requirements for urinary kidney injury molecule-1 (KIM-1) measurements in humans
  28. Kidney stones in a Mediterranean population from the south of Spain
  29. Reference Values and Biological Variations
  30. First trimester biochemistry at different maternal ages
  31. Age- and gender-related alteration in plasma advanced oxidation protein products (AOPP) and glycosaminoglycan (GAG) concentrations in physiological ageing
  32. Cancer Diagnostics
  33. Direct sequencing in cytological specimens as a useful strategy for detecting EGFR mutations in non-small cell lung cancer patients
  34. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics
  35. Letters to the Editor
  36. Aberrant results observed with four immuno-assays for total and free prostate-specific antigen (PSA) determination: a case-report
  37. Assay-dependent abnormalities in measurements of prostate-specific antigen in serum: an occasional occurrence, but of clinical significance
  38. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain κ and λ to polyclonal antibody-based assays and immunofixation electrophoresis
  39. Agarose-gel electrophoresis for the diagnosis of mucopolysaccharidoses
  40. Leptin levels in exhaled breath condensate from asthmatic children: a pilot study
  41. Masthead
  42. Masthead
Downloaded on 15.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.787/html
Scroll to top button